FGF21 and metabolic disease: Even though FGF-21 analogs are currently undergoing clinical trials and that FGF-21 has emerged as a viable therapeutic target for metabolic disorders, particular consideration should be given to reported side effects in relation to a potential use in gouty arthritis.35